Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 2
2004 1
2007 3
2008 2
2009 1
2010 4
2011 2
2013 4
2014 7
2015 11
2016 12
2017 15
2018 11
2019 12
2020 24
2021 24
2022 17
2023 14
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Practice Guideline: Age-Related Hearing Loss.
Tsai Do BS, Bush ML, Weinreich HM, Schwartz SR, Anne S, Adunka OF, Bender K, Bold KM, Brenner MJ, Hashmi AZ, Keenan TA, Kim AH, Moore DJ, Nieman CL, Palmer CV, Ross EJ, Steenerson KK, Zhan KY, Reyes J, Dhepyasuwan N. Tsai Do BS, et al. Among authors: anne s. Otolaryngol Head Neck Surg. 2024 May;170 Suppl 2:S1-S54. doi: 10.1002/ohn.750. Otolaryngol Head Neck Surg. 2024. PMID: 38687845
Clinical Practice Guideline: Age-Related Hearing Loss Executive Summary.
Tsai Do BS, Bush ML, Weinreich HM, Schwartz SR, Anne S, Adunka OF, Bender K, Bold KM, Brenner MJ, Hashmi AZ, Kim AH, Keenan TA, Moore DJ, Nieman CL, Palmer CV, Ross EJ, Steenerson KK, Zhan KY, Reyes J, Dhepyasuwan N. Tsai Do BS, et al. Among authors: anne s. Otolaryngol Head Neck Surg. 2024 May;170(5):1209-1227. doi: 10.1002/ohn.749. Otolaryngol Head Neck Surg. 2024. PMID: 38682789
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial.
Bajpai J, Kapu V, Rath S, Kumar S, Sekar A, Patil P, Siddiqui A, Anne S, Pawar A, Srinivas S, Bhargava P, Gulia S, Noronha V, Joshi A, Prabhash K, Banavali S, Sarin R, Badwe R, Gupta S. Bajpai J, et al. Among authors: anne s. Lancet Oncol. 2024 Feb;25(2):246-254. doi: 10.1016/S1470-2045(23)00628-9. Epub 2024 Jan 12. Lancet Oncol. 2024. PMID: 38224701 Clinical Trial.
Attention-deficit/hyperactivity disorder in children with hearing loss.
Ramanathan D, Kipnis P, Klaas P, Aaron KA, Anne S. Ramanathan D, et al. Among authors: anne s. Int J Pediatr Otorhinolaryngol. 2023 Aug;171:111612. doi: 10.1016/j.ijporl.2023.111612. Epub 2023 Jun 9. Int J Pediatr Otorhinolaryngol. 2023. PMID: 37329702
149 results